KR930703281A - 벤즈옥사 축합 고리 화합물, 그의 제조방법 및 이를 함유한 약제 조성물 - Google Patents

벤즈옥사 축합 고리 화합물, 그의 제조방법 및 이를 함유한 약제 조성물

Info

Publication number
KR930703281A
KR930703281A KR1019930701956A KR930701956A KR930703281A KR 930703281 A KR930703281 A KR 930703281A KR 1019930701956 A KR1019930701956 A KR 1019930701956A KR 930701956 A KR930701956 A KR 930701956A KR 930703281 A KR930703281 A KR 930703281A
Authority
KR
South Korea
Prior art keywords
group
alkyl
represented
acyl
atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1019930701956A
Other languages
English (en)
Korean (ko)
Inventor
시오따 다쯔끼
다께야스 다꾸미
가따오까 겐이찌로
모찌즈끼 쯔도무
다나베 히로후미
오따 미끼오
가노 마사또시
야마구찌 히사오
Original Assignee
히로시 이따가끼
데이진 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 히로시 이따가끼, 데이진 가부시끼가이샤 filed Critical 히로시 이따가끼
Publication of KR930703281A publication Critical patent/KR930703281A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D263/57—Aryl or substituted aryl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Furan Compounds (AREA)
KR1019930701956A 1990-12-28 1991-12-27 벤즈옥사 축합 고리 화합물, 그의 제조방법 및 이를 함유한 약제 조성물 Withdrawn KR930703281A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP415443/1990 1990-12-28
JP41544390 1990-12-28
JP2914391 1991-01-31
JP29143/1991 1991-01-31
PCT/JP1991/001793 WO1992012144A1 (en) 1990-12-28 1991-12-27 Condensed benzoxa ring compound, production thereof, and pharmaceutical composition containing the same

Publications (1)

Publication Number Publication Date
KR930703281A true KR930703281A (ko) 1993-11-29

Family

ID=26367294

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930701956A Withdrawn KR930703281A (ko) 1990-12-28 1991-12-27 벤즈옥사 축합 고리 화합물, 그의 제조방법 및 이를 함유한 약제 조성물

Country Status (11)

Country Link
US (1) US5496853A (enExample)
EP (1) EP0632031B1 (enExample)
JP (1) JP3095413B2 (enExample)
KR (1) KR930703281A (enExample)
AT (1) ATE192446T1 (enExample)
AU (1) AU652981B2 (enExample)
CA (1) CA2098912A1 (enExample)
DE (1) DE69132167T2 (enExample)
ES (1) ES2145743T3 (enExample)
HU (1) HUT68721A (enExample)
WO (1) WO1992012144A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992012144A1 (en) * 1990-12-28 1992-07-23 Teijin Limited Condensed benzoxa ring compound, production thereof, and pharmaceutical composition containing the same
US5451596A (en) * 1992-12-29 1995-09-19 Rhone Poulenc Rorer Pharmaceuticals Inc. Cycloalkyl amine bis-aryl squalene synthase inhibitors
GB9312853D0 (en) 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5591776A (en) 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US5922751A (en) 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US5665737B1 (en) * 1994-10-12 1999-02-16 Euro Celtique Sa Substituted benzoxazoles
US6372770B1 (en) 1994-10-12 2002-04-16 Euro-Celtique, S.A. Benzoxazoles
JPH10508032A (ja) * 1994-12-13 1998-08-04 ユーロ−セルティーク，エス．エイ． アリールチオキサンチン類
US6025361A (en) * 1994-12-13 2000-02-15 Euro-Celtique, S.A. Trisubstituted thioxanthines
EP0799040B1 (en) 1994-12-13 2003-08-20 Euroceltique S.A. Trisubstituted thioxanthines
US6166041A (en) 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
CA2190708A1 (en) * 1995-12-08 1997-06-09 Johannes Aebi Aminoalkyl substituted benzo-heterocyclic compounds
US5684041A (en) * 1996-02-01 1997-11-04 The Procter & Gamble Company Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
US6075016A (en) 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
KR100215541B1 (ko) * 1996-04-19 1999-08-16 박원훈 벤족사졸계 비선형 광학 유도체 및 이들로부터 얻어진고분자
US5864037A (en) 1996-06-06 1999-01-26 Euro-Celtique, S.A. Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
US5744473A (en) * 1996-09-16 1998-04-28 Euro-Celtique, S.A. PDE IV inhibitors: "bis-compounds"
PT1136477E (pt) 1998-12-04 2004-08-31 Takeda Chemical Industries Ltd Derivados do benzofurano processo para a sua preparacao e suas utilizacoes
US7465815B2 (en) * 2003-06-26 2008-12-16 Takeda Pharmaceutical Company Limited Cannabinoid receptor modulator
US7601856B2 (en) 2006-07-27 2009-10-13 Wyeth Benzofurans as potassium ion channel modulators
TWI652014B (zh) 2013-09-13 2019-03-01 美商艾佛艾姆希公司 雜環取代之雙環唑殺蟲劑
US20180368404A1 (en) * 2014-11-06 2018-12-27 Basf Se 3-pyridyl heterobicyclic compound for controlling invertebrate pests

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3634462A (en) * 1968-06-26 1972-01-11 Fmc Corp 2 3-dihydro-2 2-dimethyl-7-aceto acetamidobenzofuran
US3651141A (en) 1969-08-08 1972-03-21 Sandoz Ag 2 6-di(lower alkanoylamino)- 3 4-dichlorophenols
JPS6031208B2 (ja) * 1974-07-10 1985-07-20 帝人株式会社 ポリアミド溶液
US4297349A (en) * 1980-04-15 1981-10-27 Sandoz, Inc. Silicon-bearing carboxylic acids and amides
US4296240A (en) * 1980-04-24 1981-10-20 Sandoz, Inc. Silacycloalkane amides
DE3008812A1 (de) * 1980-03-07 1981-09-24 Hoechst Ag, 6000 Frankfurt Mischungen von optischen aufhellern
US4649149A (en) * 1980-05-22 1987-03-10 Ciba-Geigy Corporation Process for the manufacture of novel benzazole derivatives, pharmaceutical preparations containing these derivatives, and their use
MA19290A1 (fr) * 1980-05-22 1982-04-01 Ciba Geigy Ag Derives du benzole,leur preparaton et leur utilisations therapeutiques .
JPS60215680A (ja) * 1984-04-10 1985-10-29 Mitsubishi Chem Ind Ltd Ｎ−２，３−ジヒドロベンゾフラニルベンズアミド誘導体およびこれを有効成分とする農園芸用殺菌剤
CA1261835A (en) * 1984-08-20 1989-09-26 Masaaki Toda (fused) benz(thio)amides
GB2169283A (en) * 1985-01-02 1986-07-09 Sumitomo Chemical Co Fungicidal aniline derivatives
JPS61233742A (ja) * 1985-04-09 1986-10-18 Konishiroku Photo Ind Co Ltd ハロゲン化銀写真感光材料
JPH075532B2 (ja) * 1985-06-04 1995-01-25 住友化学工業株式会社 ベンズアニリド誘導体およびそれを有効成分とする殺菌剤
US5002691A (en) * 1986-11-06 1991-03-26 The Clorox Company Oxidant detergent containing stable bleach activator granules
EP0297610B1 (en) * 1987-07-02 1991-03-13 Warner-Lambert Company N-[(2,6-disubstituted)phenyl]-urea and carbamate inhibitors of acyl-CoA:cholesterol acyl-transferase
US4847257A (en) * 1987-08-20 1989-07-11 Merck & Co., Inc. 5-Amino or substituted amino 1,2,3,-triazoles useful as antiproliferative agents
DE3740985A1 (de) * 1987-12-03 1989-06-15 Boehringer Mannheim Gmbh Verwendung linear anellierter tricyclen als hemmer der erythrozytenaggregation
DE3809868A1 (de) * 1988-03-24 1989-10-05 Boehringer Mannheim Gmbh Neue heterocyclisch substituierte 5,7-dihydro-pyrrolo(3,2-f)benzoxazol-6-one, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
US5246927A (en) * 1988-08-17 1993-09-21 Ciba-Geigy Corporation Benzazole derivatives, processes for their preparation containing such compounds and the use thereof
TW199152B (enExample) * 1990-11-01 1993-02-01 Takeda Pharm Industry Co Ltd
US5214206A (en) * 1990-11-07 1993-05-25 Warner-Lambert Company Aminosulfonyl urea acat inhibitors
WO1992012144A1 (en) * 1990-12-28 1992-07-23 Teijin Limited Condensed benzoxa ring compound, production thereof, and pharmaceutical composition containing the same

Also Published As

Publication number Publication date
US5496853A (en) 1996-03-05
EP0632031B1 (en) 2000-05-03
AU652981B2 (en) 1994-09-15
ES2145743T3 (es) 2000-07-16
EP0632031A1 (en) 1995-01-04
DE69132167T2 (de) 2000-12-14
DE69132167D1 (de) 2000-06-08
CA2098912A1 (en) 1992-06-29
EP0632031A4 (enExample) 1995-02-08
WO1992012144A1 (en) 1992-07-23
JP3095413B2 (ja) 2000-10-03
HU9301866D0 (en) 1993-12-28
AU9110591A (en) 1992-08-17
ATE192446T1 (de) 2000-05-15
HUT68721A (en) 1995-07-28

Similar Documents

Publication Publication Date Title
FI931763A0 (fi) 4,1-bensoxazepinderivat och deras anvaendning
KR920018178A (ko) 폴리글리시딜 화합물의 경화제로서의 용도 및 이들 성분을 함유하는 분말 코팅 조성물
KR840008021A (ko) 4-치환된-2-아제티디논 화합물의 제조방법
KR930702324A (ko) 탁산 유도체 제조 방법, 이로써 얻어진 신규한 유도체 및 상기를 함유한 제약학적 조성물
KR950000693A (ko) 프로펜산 유도체
KR870003977A (ko) 4번위치에서의 페닐잔기가 치환된 술포닐페닐 알킬아민 및 그의 유도체 제조방법 및 이화합물을 함유한 약제 조성물
KR960701881A (ko) 나프탈렌포스폰산의 우레이도 유도체 및 이의 제조 방법(Ureido derivatives of naphtha1enephosphonic acids and process for their preparation)
KR910000628A (ko) 디페닐우레아 유도체, 그의 제조방법 및 그를 함유하는 조성물
RU93005332A (ru) Производные 4,1-бензоксазепина, фармацевтическая композиция, способ лечения
KR850001905A (ko) 벤조시클로 알칸 유도체의 제조방법
KR950703503A (ko) 4-알콕시-2,6-디-t-부틸페놀 유도체(4-ALKOXY-2,6-DI-t-BUTYLPHENOL DERIVATVE)
KR860000293A (ko) 함암작용을 갖는 푸란유도체의 제조방법
KR900000351A (ko) 1-아릴-나프토일아민 및 그의 제조방법
KR900007858A (ko) 페닐알리파틸 아미노 알칸디포스폰산
KR910021397A (ko) 광학 활성인 8-메톡시퀴놀론카복실산 유도체, 이의 제조방법 및 이의 중간체
KR910016710A (ko) 4-페닐프탈라진 유도체
KR920018036A (ko) 티아졸리디논 및 옥사졸리디논 유도체, 그의 제조방법 및 혈관확장제로서의 용도
KR970707122A (ko) 퀴놀린 유도체(quinoline derivative)
DK0548338T3 (da) Fremgangsmåde til fremstilling af cephalosporinmellemprodukter
KR840000565A (ko) 세펨 화합물의 제조방법
LV10235A (lv) Jauni esteri to iegusanas panemiens farmaceitiska kompozicija arstesanas metode
KR870007881A (ko) 신규 알킬렌디아민 유도체의 제조방법
KR910016689A (ko) 우레아 유도체 및 이의 염, 이를 함유하는 약제학적 조성물 및 이의 제조방법
MY106303A (en) Hydroxyimidazolines and polyamine fuel additive compositions
KR840005723A (ko) 티아졸유도체의 제조방법

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19930626

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid